Literature DB >> 29182210

The role of point-of-care ultrasound in intra-abdominal hypertension management.

Bruno M Pereira1, Renato G Pereira, Robert Wise, Gavin Sugrue, Tanya L Zakrison, Alcir E Dorigatti, Rossano K Fiorelli, Manu L N G Malbrain.   

Abstract

BACKGROUND: Intra-abdominal hypertension is a common complication in critically ill patients. Recently the Abdominal Compartment Society (WSACS) developed a medical management algorithm with a stepwise approach according to the evolution of the intra-abdominal pressure and aiming to keep IAP ≤ 15 mm Hg. With the increased use of ultrasound as a bedside modality in both emergency and critical care patients, we hypothesized that ultrasound could be used as an adjuvant point-of-care tool during IAH management. This may be particularly relevant to the first and second basic stages of the algorithm. The objective of this paper is to test the use of POCUS as an adjuvant tool in the management of patients with IAH/ACS.
METHODS: Seventy-three consecutive adult critically ill patients admitted to the surgical intensive care unit (ICU) of a single urban institution with risk factor for IAH/ACS were enrolled. Those who met the inclusion criteria were allocated to undergo POCUS as an adjuvant tool in their IAH/ACS management.
RESULTS: A total of 50 patients met the inclusion criteria and were included in the study. The mean age of study participants was 55 ± 22.6 years, 58% were men, and the most frequent admission diagnosis was post-operative care following abdominal intervention. All admitted patients presented with a degree of IAH during their ICU stay. Following step 1 of the WSACS IAH medical management algorithm, ultrasound was used for NGT placement, confirmation of correct positioning, and evaluation of stomach contents. Ultrasound was comparable to abdominal X-ray, but shown to be superior in determining the gastric content (fluid vs. solid). Furthermore, POCUS allowed faster determination of correct NGT positioning in the stomach (antrum), avoiding bedside radiation exposure. Ultrasound also proved useful in: 1) evaluation of bowel activity; 2) identification of large bowel contents; 3) identification of patients that would benefit from bowel evacuation (enema) as an adjuvant to lower IAP; 4) and in the diagnosis of moderate to large amounts of free intra-abdominal fluid.
CONCLUSION: POCUS is a powerful systematic ultrasound technique that can be used as an adjuvant in intra-abdominal hypertension management. It has the potential to be used in both diagnosis and treatment during the course of IAH.

Entities:  

Keywords:  POCUS; intra-abdominal compartment syndrome; intra-abdominal hypertension; point-of-care ultrasound; ultrasound

Mesh:

Year:  2017        PMID: 29182210     DOI: 10.5603/AIT.a2017.0074

Source DB:  PubMed          Journal:  Anaesthesiol Intensive Ther        ISSN: 1642-5758


  3 in total

1.  Predictive value of transabdominal intestinal sonography in critically ill patients: a prospective observational study.

Authors:  Tao Gao; Min-Hua Cheng; Feng-Chan Xi; Yan Chen; Chun Cao; Ting Su; Wei-Qin Li; Wen-Kui Yu
Journal:  Crit Care       Date:  2019-11-27       Impact factor: 9.097

2.  Ultrasonography in the diagnosis and monitoring of intra-abdominal hypertension and abdominal compartment syndrome: Ultrasonografia a nadciśnienie wewnątrzbrzuszne i zespół przedziału brzusznego.

Authors:  Andrzej Smereczyński; Katarzyna Kołaczyk; Elżbieta Bernatowicz
Journal:  J Ultrason       Date:  2020-09-28

3.  International evidence-based guidelines on Point of Care Ultrasound (POCUS) for critically ill neonates and children issued by the POCUS Working Group of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC).

Authors:  Yogen Singh; Cecile Tissot; María V Fraga; Nadya Yousef; Rafael Gonzalez Cortes; Jorge Lopez; Joan Sanchez-de-Toledo; Joe Brierley; Juan Mayordomo Colunga; Dusan Raffaj; Eduardo Da Cruz; Philippe Durand; Peter Kenderessy; Hans-Joerg Lang; Akira Nishisaki; Martin C Kneyber; Pierre Tissieres; Thomas W Conlon; Daniele De Luca
Journal:  Crit Care       Date:  2020-02-24       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.